During the past decade, Guangzhou Institute of Respiratory Disease conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guangzhou Institute of Respiratory Disease" #1 sponsor was "Guangzhou Institute of Respiratory Disease" with 32 trials, followed by "The First Affiliated Hospital of Guangzhou Medical University" with 11 trials sponsored, "Beijing Chao Yang Hospital" with 2 trials sponsored, "Guangzhou Medical University" with 1 trials sponsored and "Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guangzhou Institute of Respiratory Disease" #1 collaborator was "Dongguan People's Hospital" with 2 trials as a collaborator, "Firestone Institute for Respiratory Health" with 2 trials as a collaborator, "GeneCast Biotechnology Co., Ltd." with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Second Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Guangzhou Institute of Respiratory Disease" are "Asthma" (5 trials), "Chronic Obstructive Pulmonary Disease" (5 trials), "Bronchiectasis" (4 trials), "Hypercapnic Respiratory Failure" (3 trials) and "Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Guangzhou Institute of Respiratory Disease" in a lesser frequency.

Most popular intervention types in "Guangzhou Institute of Respiratory Disease" are "Drug" (20 trials), "Device" (11 trials), "Other" (7 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Montelukast" (2 trials), "Theophylline" (2 trials), "Anti-NY-ESO-1 TCR transduced T cells" (1 trials) and "Antibiotics" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guangzhou Institute of Respiratory Disease" are 49 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Guangzhou Institute of Respiratory Disease". 3 are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Guangzhou Institute of Respiratory Disease, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guangzhou Institute of Respiratory Disease, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 18 trials that are defined as “Not Applicable".